
Even if you've never smoked, you could still be at risk of lung cancer, doctors warn
While it's true that those who smoke face a much higher risk, up to 20% of lung cancers affect people who have never smoked or have smoked fewer than 100 cigarettes in their lifetime, according to the U.S. Centers for Disease Control and Prevention (CDC).
Despite this, the US Preventive Services Task Force (USPSTF) does not recommend lung cancer screening for those who have never smoked, as the agency states the risks may outweigh the potential benefits.
Most lung cancers fall into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), according to the American Cancer Society.
NSCLC, which encompasses about 80% to 85% of all lung cancers, includes adenocarcinoma (common in non-smokers), squamous cell carcinoma and large cell carcinoma.
7 While it's true that those who smoke face a much higher risk, up to 20% of lung cancers affect people who have never smoked.
Tetiana – stock.adobe.com
The remaining lung cancers are classified as SCLC, a more aggressive type that tends to spread faster and has a poorer prognosis.
Mohamed Abazeed, M.D., Ph.D., chair of radiation oncology and the William N. Brand Professor at the Northwestern University Feinberg School of Medicine in Chicago, agrees that the share of lung cancers diagnosed in never-smokers is increasing, particularly among women and patients of Asian ancestry.
'While overall incidence is declining due to reduced smoking rates, the relative share of never-smokers is growing and is reflected in clinical practice, where we increasingly diagnose patients without a traditional smoking history,' he told Fox News Digital.
7 Most lung cancers fall into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
utah51 – stock.adobe.com
Dr. Lauren Nicola, a practicing radiologist and chief medical officer at Reveal Dx in North Carolina, said she is also seeing an increase in the rate of newly diagnosed lung cancer in non-smokers, particularly among women and younger adults.
The main factor driving up the share of non-smokers among lung cancer patients, according to Abazeed, is the successful drive to reduce tobacco consumption in the U.S.
'Other factors include improvements in imaging and broader use of CT scans that have enhanced early-stage tumor detection,' he noted.
'Evolving environmental factors may also be contributing to this change, with pollutants potentially driving lung inflammation, which in turn has been implicated in cancer development.'
Modifiable risk factors
7 The main factor driving up the share of non-smokers among lung cancer patients is the successful drive to reduce tobacco consumption in the U.S.
New Africa – stock.adobe.com
Some of the biggest non-smoking risk factors for lung cancer include ambient air pollution and secondhand smoke, according to Abazeed.
Exposure to thoracic radiation (high-energy radiation in the chest area) — along with occupational hazards like radon, asbestos and diesel exhaust — can also increase the risk.
Lifestyle-related inflammation, which is often linked to poor diet and sedentary behavior, can also play a role, Nicola noted.
7 Some of the biggest non-smoking risk factors for lung cancer include ambient air pollution and secondhand smoke, according to Abazeed.
utah51 – stock.adobe.com
'Some of these, like radon and air quality, can be addressed at the household or policy level,' Abazeed said.
'Lifestyle interventions — such as exercise, diet and avoidance of indoor pollutants — may play a modest protective role.'
Both doctors pointed out that former smokers, especially those who smoked more often and for longer periods of time, remain at elevated risk even decades after quitting.
'The greater the number of pack-years, the higher the risk,' said Nicola. 'Risk declines over time after quitting, but never returns to the baseline of a never-smoker.'
Genetic risk factors
7 Doctors pointed out that former smokers remain at elevated risk even decades after quitting.
Photographee.eu – stock.adobe.com
Some people inherit a higher risk of developing lung cancer due to their DNA.
'It is estimated that about 8% of lung cancers are inherited or occur because of a genetic predisposition,' Abazeed told Fox News Digital.
'Inherited predisposition is an area of active investigation, particularly in younger patients or those with a strong family history.'
Having a first-degree relative with lung cancer roughly doubles the risk of developing the disease, even after controlling for smoking exposure, according to Nicola.
'Cancers in non-smokers are more often associated with specific genetic mutations and genomic profiles,' she said. 'This suggests that these malignancies have a different underlying biology compared to tumors in smokers.'
Screenings in question
7 Having a first-degree relative with lung cancer roughly doubles the risk of developing the disease, even after controlling for smoking exposure.
didesign – stock.adobe.com
Current U.S. screening guidelines call for annual low-dose CT scans for high-risk individuals based on age and smoking history, Abazeed reiterated.
The USPSTF recommends screening for 'adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.'
'There is a growing interest in expanding eligibility to include non-smoking risk factors,' Abazeed noted. 'Evidence is accumulating that could potentially change current population-wide guidelines.'
7 Current U.S. screening guidelines call for annual low-dose CT scans for high-risk individuals based on age and smoking history.
Doodeez – stock.adobe.com
There are some potential risks linked to expanding screening, experts say, including the potential for overdiagnosis and false positives.
'The problem with screening everyone for lung cancer is that up to 50% of all chest CTs will detect at least one pulmonary nodule,' Nicola noted. 'The vast majority of these nodules are benign, but a small percentage will turn out to be cancer.'
Based primarily on the size of the nodule, the clinician may recommend follow-up imaging or biopsy.
'New tools are being developed that can help us better characterize the malignancy risk of a nodule, which will decrease the potential for harm associated with overdiagnosis in screening,' Nicola said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
CDC director: Misinformation 'lead to deadly consequence" in Atlanta
Aug. 13 (UPI) -- The director of the Centers for Disease Control and Prevention told employees about the dangers of misinformation, four days after a suspected gunman shot at the agency's headquarters in Atlanta, claiming the COVID-19 vaccine made him sick. On Tuesday, Susan Monarez met with staffers virtually and then sent a note to all 10,000 employees nationwide, obtained by ABC News. Staffers at the headquarters have been working remotely since the attack on Friday. "The dangers of misinformation and its promulgation has now led to deadly consequences," she wrote. "I will work to restore trust in public health to those who have lost it -- through science, evidence and clarity of purpose. I will need your help." The comments were slightly different than those during her staff meeting in which she said: "Public health should never be under attack. We know that misinformation can be dangerous." She said the health agency can rebuild trust with "rational evidence-based discourse" with "compassion and understanding." Dr. Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Pennsylvania, told NBC News: "The irony is her boss is the biggest spreader of misinformation." Robert F. Kennedy Jr. is secretary of the Health and Human Services, which oversees the CDC. In 2021, during the pandemic, Kennedy described the shot as the "deadliest vaccine ever made" after he filed a citizens' petition requesting that the Food and Drug Administration end emergency authorization. Last week, Kennedy announced that HHS was moving to terminate $500 million in contracts to develop vaccines using mRNA technology, which was used to develop the COVID-19 vaccine in 2020. "After reviewing the science and consulting top experts at NIH [National Institutes of Health] and FDA, HHS has determined that mRNA technology poses more risks than benefits for these respiratory viruses," The American Medical Association backs mRNA vaccine research and the CDC still says on its website: "During the COVID-19 pandemic, COVID-19 vaccines underwent the most intensive safety analysis in U.S. history." Health officials have denounced skepticism of the research, noting the COVID-19 vaccine saved millions of lives in the United States. "The Covid pandemic showed us what's possible when science moves fast," Rick Bright, who directed the Biomedical Advanced Research and Development from 2016 to 2020, told NBC News. "Dismantling that momentum now is like disbanding the fire department because the fire's out." As head of the HHS, he has updated COVID-19 vaccine recommendations for the fall to be restricted to older adults and those with underlying health conditions. He also doesn't want children to get the shots. On Monday, Kennedy toured the CDC campus in Atlanta and met with the widow of the one person slain in the attack, DeKalb County Police Officer David Rose. He toured with Monarez and HHS Deputy Secretary Jim O'Neill. "He offered his deepest condolences and reaffirmed the agency's commitment to honoring officer Rose's bravery, sacrifice and service to the nation," HHS said. Since the attack, the union representing CDC workers condemned the lack of support from top officials. "This leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails," the union said Sunday. "This condemnation is necessary to help prevent violence against scientists that may be incited by such disinformation." The American Federation of Government Employees Local 2883, which represents more than 2,000 CDC workers, said in a statement Sunday that the attack "was not random and it compounds months of mistreatment, neglect and vilification that CDC staff have endured." The union also said: "The deliberate targeting of CDC through this violent act is deeply disturbing, completely unacceptable and an attack on every public servant." The father of the suspected gunman, 30-year-old Patrick Joseph White, reportedly told authorities he targeted the CDC over health problems he blamed on the COVID-19 vaccine. He said the shot made him depressed and suicidal. He was fatally shot by police after around 200 bullets struck the six buildings. Five firearms were recovered. "All indications are that this was an isolated event involving one individual," Jeff Williams, the deputy secretary of the CDC's Office of Safety, Security and Asset Management, said during the staff meeting Tuesday.


UPI
3 hours ago
- UPI
CDC director: Misinformation 'lead to deadly consequence" in Atlanta
The U.S. Centers for Disease Control and Prevention headquarters in Atlanta was attacked by a gunman on Friday. File Photo by Erike S. Lesser/EPA Aug. 13 (UPI) -- The director of the Centers for Disease Control and Prevention told employees about the dangers of misinformation, four days after a suspected gunman shot at the agency's headquarters in Atlanta, claiming the COVID-19 vaccine made him sick. On Tuesday, Susan Monarez met with staffers virtually and then sent a note to all 10,000 employees nationwide, obtained by ABC News. Staffers at the headquarters have been working remotely since the attack on Friday. "The dangers of misinformation and its promulgation has now led to deadly consequences," she wrote. "I will work to restore trust in public health to those who have lost it -- through science, evidence and clarity of purpose. I will need your help." The comments were slightly different than those during her staff meeting in which she said: "Public health should never be under attack. We know that misinformation can be dangerous." She said the health agency can rebuild trust with "rational evidence-based discourse" with "compassion and understanding." Dr. Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Pennsylvania, told NBC News: "The irony is her boss is the biggest spreader of misinformation." Robert F. Kennedy Jr. is secretary of the Health and Human Services, which oversees the CDC. In 2021, during the pandemic, Kennedy described the shot as the "deadliest vaccine ever made" after he filed a citizens' petition requesting that the Food and Drug Administration end emergency authorization. Last week, Kennedy announced that HHS was moving to terminate $500 million in contracts to develop vaccines using mRNA technology, which was used to develop the COVID-19 vaccine in 2020. "After reviewing the science and consulting top experts at NIH [National Institutes of Health] and FDA, HHS has determined that mRNA technology poses more risks than benefits for these respiratory viruses," The American Medical Association backs mRNA vaccine research and the CDC still says on its website: "During the COVID-19 pandemic, COVID-19 vaccines underwent the most intensive safety analysis in U.S. history." Health officials have denounced skepticism of the research, noting the COVID-19 vaccine saved millions of lives in the United States. "The Covid pandemic showed us what's possible when science moves fast," Rick Bright, who directed the Biomedical Advanced Research and Development from 2016 to 2020, told NBC News. "Dismantling that momentum now is like disbanding the fire department because the fire's out." As head of the HHS, he has updated COVID-19 vaccine recommendations for the fall to be restricted to older adults and those with underlying health conditions. He also doesn't want children to get the shots. On Monday, Kennedy toured the CDC campus in Atlanta and met with the widow of the one person slain in the attack, DeKalb County Police Officer David Rose. He toured with Monarez and HHS Deputy Secretary Jim O'Neill. "He offered his deepest condolences and reaffirmed the agency's commitment to honoring officer Rose's bravery, sacrifice and service to the nation," HHS said. Today I traveled to Atlanta in the wake of the heartbreaking shooting at the CDC's Roybal Campus that took the life of DeKalb County Police Officer David Rose. @POTUS and the entire administration are deeply saddened by this tragic loss. We stand with Officer Rose's wife, his two... Secretary Kennedy (@SecKennedy) August 11, 2025 Since the attack, the union representing CDC workers condemned the lack of support from top officials. "This leadership is critical in reinforcing public trust and ensuring that accurate, science-based information prevails," the union said Sunday. "This condemnation is necessary to help prevent violence against scientists that may be incited by such disinformation." The American Federation of Government Employees Local 2883, which represents more than 2,000 CDC workers, said in a statement Sunday that the attack "was not random and it compounds months of mistreatment, neglect and vilification that CDC staff have endured." The union also said: "The deliberate targeting of CDC through this violent act is deeply disturbing, completely unacceptable and an attack on every public servant." The father of the suspected gunman, 30-year-old Patrick Joseph White, reportedly told authorities he targeted the CDC over health problems he blamed on the COVID-19 vaccine. He said the shot made him depressed and suicidal. He was fatally shot by police after around 200 bullets struck the six buildings. Five firearms were recovered. "All indications are that this was an isolated event involving one individual," Jeff Williams, the deputy secretary of the CDC's Office of Safety, Security and Asset Management, said during the staff meeting Tuesday.
Yahoo
5 hours ago
- Yahoo
One in four US adults with diabetes used a GLP-1 drug last year, survey finds
By Bhanvi Satija (Reuters) -More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the U.S. Centers for Disease Control and Prevention said on Thursday. The wildly popular and effective GLP-1 drugs Mounjaro from Eli Lilly and Ozempic from Novo Nordisk are approved in the United States for treating type 2 diabetes. They are sold as Zepbound and Wegovy, respectively, for weight loss and are being tested for other conditions. Use of the injectable drugs was highest among adults with diabetes aged 50–64 at 33.3%, reflecting the more significant disease burden in this group, the report said. A quarter or 25.3% of adults with diabetes aged 18 to 34 reported using a GLP-1 drug, while the adoption rate was 20.8% among those 65 and older. The data are from a nationally representative annual survey of U.S. adults aged 18 and older that was conducted in person and with follow-up by phone in 2024. In 2024, for the first time, participants in the annual survey who had diabetes were asked if they were using the Lilly or Novo blockbusters or other GLP-1 drugs to lower blood sugar or lose weight. The drugs mimic the activity of a hormone that regulates blood sugar levels, slows digestion and helps people feel full for longer. Drugmakers Lilly and Novo have faced criticism about the cost of the treatments, which carry a list price of about $1,000 for a month's supply. Roughly 31% of survey participants who reported using insulin also reported using GLP-1 drugs, as did about 28% of patients who were using oral drugs to control their blood sugar, according to the report, indicating that these treatments are being integrated into combination regimens. Hispanic adults with diabetes had the highest rate of GLP-1 use, at 31.3%, followed by Black non-Hispanic and White non-Hispanic adults, at 26.5% and 26.2%, respectively, the survey found. Only 12.1% of Asian non-Hispanic adults with diabetes used the drugs, which may reflect disparities in access or adoption of the therapies. Solve the daily Crossword